Intra Cellular Therapies shares owned by Hillsdale Investment Management
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Hillsdale Investment Management
from 13F filings
Historical chart of Hillsdale Investment Management investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by Hillsdale Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intra Cellular Therapies by Hillsdale Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $6.2k | 90 | 68.49 |
| 2024-03-31 | $5.5k | 80 | 69.20 |
| 2023-12-31 | $5.7k | 80 | 71.63 |
| 2023-09-30 | $2.6M | 51k | 52.09 |
| 2023-06-30 | $3.1M | 49k | 63.32 |
| 2023-03-31 | $4.6M | 85k | 54.15 |
| 2022-12-31 | $5.1M | 96k | 52.92 |
| 2022-09-30 | $4.4M | 94k | 46.49 |
| 2022-06-30 | $805k | 14k | 57.09 |
More positions owned by Hillsdale Investment Management
View all positions for Hillsdale Investment Management
Top funds holding Intra Cellular Therapies
View all funds holding Intra Cellular Therapies